Discounted Cash Flow (DCF) Analysis Levered

Biomerica Inc

Biomerica Inc (BMRA)

$5.475
-0.135 (-2.41%)

Free Cash Flow

Year
A/P
Revenue
Revenue (%)
Operating Cash Flow
Operating Cash Flow (%)
Capital Expenditure
Capital Expenditure (%)
Free Cash Flow

Weighted Average Cost Of Capital

Share price $ 5.475
Beta -0.884
Diluted Shares Outstanding 10,166.30
Cost of Debt
Tax Rate -0.32
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity -4.580
Total Debt 211.81
Total Equity 55,660.47
Total Capital 55,872.28
Debt Weighting 0.38
Equity Weighting 99.62
Wacc

Build Up Free Cash Flow

Year
A/P
Revenue
Operating Cash Flow
Capital Expenditure
Free Cash Flow
WACC
PV LFCF
SUM PV LFCF

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -8.64
Equity Value -
Shares Outstanding 10,166.30
Equity Value Per Share -